A Phase I Dosimetry, Biodistribution and Safety Study of BMS747158 in Healthy Subjects Undergoing 2-Day Rest/Stress Positron Emission Tomography

NCT00707538 Phase 1 COMPLETED

The purpose of this clinical research study is to learn the biodistribution of injection of BMS747158 at stress and assess the safety of two doses of BMS747158

Details

Lead sponsor	Lantheus Medical Imaging
Phase	Phase 1
Status	COMPLETED
Enrolment	12
Start date	2008-06
Completion	2008-10

Conditions

• Healthy Volunteers

Interventions

• BMS747158

Primary outcomes

• Dosimetry analysis following whole body imaging after stress injection — Imaging takes place approximately 0 - 300 minutes post injection

Countries

United States